Regulations

(Image: Getty/Thida Ratn Caem Caeng  EyeEm)

Q&A

2018: An inflection point for generics

By Flora Southey

Generics drug portfolios are diversifying, prices are stabilising, and while competition remains intense, the worst of price erosion appears to be over, claims Clarivate Analytics executive.

(Image: Getty/Светлана Зайцева)

US farm bill a boon for pharma?

By Flora Southey

If approved by President Trump, the five-year farm bill – which removes hemp from the federal controlled substance list – could help advance cannabinoid R&D, says Nexien Biopharma.

(Image: Getty/ugurhan)

Boehringer reshuffle cuts 327 jobs in France

By Flora Southey

Boehringer says it will reduce its workforce in France, including 182 positions in human health, to streamline operations in ‘deteriorating markets’.